04:39 PM EDT, 07/08/2025 (MT Newswires) -- RxSight ( RXST ) shares fell over 30% during Tuesday after-hours trading after it reported preliminary Q2 revenue of $33.6 million, down from $34.9 million a year earlier.

Analysts polled by FactSet expect $39.8 million.

The company cut its full-year 2025 revenue guidance to $120 million to $130 million from $160 million to $175 million earlier. Analysts surveyed by FactSet expect $167.6 million.